EUVIMEDEUVIMED entdecken
Crossref

Revisiting the steatosis‐associated fibrosis estimator score in young Asian subjects with steatotic liver disease and consideration for population variability

Jiwon Yang, Won-Mook Choi iD, Danbi Lee, Ju Hyun Shim, Kang Mo Kim iD, Young-Suk Lim iD, Han Chu Lee iD, Jonggi Choi iD

Journal of Gastroenterology and Hepatology · 2024

DOI: 10.1111/jgh.16656 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Jiwon Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Liver Cirrhosis, Asian People, Fatty Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: National Research Foundation of Korea, Gilead Sciences Research Scholar Program, Gilead Research Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim The steatosis‐associated fibrosis estimator (SAFE) score has been developed to distinguish clinically significant fibrosis in patients with steatotic liver disease (SLD). However, validation of its performance in Asian subjects is limited. This study aimed to evaluate the performance of the SAFE score in Asian subjects with biopsy‐proven SLD and in different subgroups according to age, sex, and body mass index.

Methods

We retrospectively analyzed 6383 living liver donors who underwent a liver biopsy between 2005 and 2023. Of these, 1551 subjects with biopsy‐proven SLD were included. The performance of the SAFE score was evaluated using areas under the curve and compared with those of the nonalcoholic fatty liver disease fibrosis score (NFS) and fibrosis‐4 index (FIB‐4).

Results

The prevalence of clinically significant fibrosis in the cohort was 2.2%. The proportion of subjects with a “low‐risk” SAFE score was the highest (91.0%), followed by those with “intermediate‐risk” (7.8%) and “high‐risk” (1.2%) scores. The prevalence of fibrosis in subjects with low‐risk, intermediate‐risk, and high‐risk scores was 1.6%, 6.6%, and 21.1%, respectively. The SAFE outperformed FIB‐4 and NFS (area under the curve: 0.70 vs 0.64 for both NFS and FIB‐4). However, it showed low diagnostic accuracy and sensitivity (27%) at the low cutoff (SAFE < 0) in subjects aged 30–39 years (fibrosis: 1.2%), despite having a high negative predictive value (0.99).

Conclusion

While the SAFE score demonstrates superior performance compared with other noninvasive tests in Asian subjects with SLD, its performance varies across age groups. In younger subjects, particularly, its performance may be more limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisAsian PeopleFatty LiverHumansFemaleMaleAdultRetrospective StudiesAge FactorsPrevalenceMiddle AgedBiopsyYoung AdultBody Mass IndexSeverity of Illness IndexNon-alcoholic Fatty Liver DiseaseBiological Variation, Population

Stichwörter der Autor:innen

liver fibrosisnoninvasive teststeatotic liver diseasethe steatosis‐associated fibrosis estimator score

Autor:innen und Institutionen

  • Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Won-Mook Choi, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi

Förderung

  • National Research Foundation of Korea
  • Gilead Sciences Research Scholar Program
  • Gilead Research Scholars

Zitieren

APA

Yang, J., Choi, W. M., Lee, D., Shim, J. H., Kim, K. M., Lim, Y. S., Lee, H. C., & Choi, J. (2024). Revisiting the steatosis‐associated fibrosis estimator score in young Asian subjects with steatotic liver disease and consideration for population variability. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16656

Vancouver

Yang J, Choi WM, Lee D, Shim JH, Kim KM, Lim YS, et al. Revisiting the steatosis‐associated fibrosis estimator score in young Asian subjects with steatotic liver disease and consideration for population variability. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16656

BibTeX
@article{Yang2024,
  author = {Yang, Jiwon and Choi, Won-Mook and Lee, Danbi and Shim, Ju Hyun and Kim, Kang Mo and Lim, Young-Suk and Lee, Han Chu and Choi, Jonggi},
  title = {Revisiting the steatosis‐associated fibrosis estimator score in young Asian subjects with steatotic liver disease and consideration for population variability},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2024},
  doi = {10.1111/jgh.16656}
}
Kostenlos starten →